ArticleAnesthesia and analgesia2025
Fine-Mapping the Association of Acute Kidney Injury With Mean Arterial and Central Venous Pressures During Coronary Artery Bypass Surgery.
Article in Anesthesia and analgesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prognostic Value of Continuous Intra-abdominal Pressure (CIAP) and Continuous Abdominal Perfusion Pressure (CAPP) Monitoring for Acute Kidney Injury (AKI) Prediuction in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Venous Return Pressure Gradient Predicts Acute Kidney Injury Onset and Progression
Who cites it
1 citing paper in PubMed.
- Cardiovascular effects of intra-abdominal hypertension: current perspectives.Anaesthesiology intensive therapy · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundPrior studies identified thresholds for mean arterial pressure (MAP <65 mm Hg) and central venous pressure (CVP >12 mm Hg) beyond which risk for cardiac surgery-associated acute kidney injury (AKI) increases. Optimal hemodynamic targets-that is, where active protection from AKI is observed-are unclear; however, current guidelines suggest maintaining MAP >65 and CVP 8 to 12. The aim of this study was to identify hemodynamic ranges associated with both increased and decreased risk of AKI by evaluating narrow ranges of MAP, CVP, and joint exposure to MAP and CVP concurrently.
methodsIn a retrospective cohort study of adults undergoing coronary artery bypass surgery, we fine-mapped the association between AKI and the total number of minutes spent in each of the following narrow hemodynamic ranges: 14 MAP ranges in increments of 5 mm Hg (45-115), 10 CVP ranges in increments of 2 mm Hg (0-20), and 70 joint MAP/CVP ranges. Separate multivariable regression models estimated adjusted odds ratios (aOR) for each range including adjustments for correlations and multiple comparisons across ranges. Joint MAP/CVP ranges were grouped into 5 hemodynamic zones based on contiguity of the ranges and similarity of ORs observed across ranges in a color-coded heatmap. The 5 MAP/CVP zones were included in a single regression model to assess risk for AKI associated with time spent in each hemodynamic zone, independent of time spent in other zones.
resultsIn 1199 participants, incidence of AKI was 28%. For every 5-minute spent in each hemodynamic range, risk of AKI was significantly increased in MAP range 45 to 50 (aOR 1.18; P = .002), 50 to 55 (aOR 1.13; P = .001), and 55 to 60 mm Hg (aOR 1.06; P = .001); and significantly decreased in MAP range 90 to 95 mm Hg (aOR 0.85; P <.001). Risk of AKI was significantly increased in CVP range 16 to 18 mm Hg (aOR 1.07 ; P = . 002) and significantly decreased in CVP range 4 to 6 mm Hg (aOR 0.97; P = . 025). In joint analyses, both MAP and CVP contributed to AKI risk estimates; risk decreased as CVP decreased within every MAP range and was significantly lower for joint ranges of CVP <8 and MAP >75. In analyses containing all 5 MAP/CVP hemodynamic zones, risk estimates suggested protection from AKI in zone 1 (high MAP/low CVP) and increased risk of AKI in zones 3 to 5 (low MAP/high CVP).
conclusionsFine-mapping identified narrow ranges of MAP, CVP, and joint MAP/CVP associated with both AKI risk and protection. This report is among the first to characterize the association between joint MAP/CVP and AKI. Contrary to current guidelines, there was no evidence for protection associated with MAP 65 to 75 or CVP 8 to 12 mm Hg.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.